Company Overview and News

General Electric Company Has Taken the First Step Towards Recovery

7h investorplace
General Electric Company (NYSE:GE) is finally doing what analysts expected, even demanded it do after John Flannery became CEO last year.

It's Time For Berkshire And McLane To Part Ways

2018-05-17 seekingalpha
The move has generated profits over this time, but with high capex and attractive multiples that peers are trading at, Berkshire should divest of the firm.

W&T Offshore: What An Impressive Recovery

2018-05-11 seekingalpha
Revenues jumped to $134.21 million in Q1'18, up 7.9% from a year ago and up 4% sequentially.

Crude Oil Keeps On Going

2018-05-11 seekingalpha
Crude oil has had some kind of week. In fact, 2018 has been a very bullish year for the energy commodity after the high-flying final six months of 2017.

Valuation Dashboard: Materials And Energy - Update

2018-05-07 seekingalpha
This article series provides a monthly dashboard of industries in each sector of the GICS classification. It compares valuation and quality factors relative to their historical averages in each industry.

National Oilwell Varco: Avoid For Now, Buy Baker Hughes

2018-05-02 seekingalpha
NOV stock has been dragged higher along with other OFS companies this year, gaining 20% +/-.

Upcoming Oil Stock Earnings to Watch: EOG, CNQ, PBA & PE

2018-05-02 zacks
We have now passed the halfway mark of the first-quarter reporting cycle. We expect the elite S&P 500 index to record year-over-year earnings growth of 22.6% in the quarter on 8.4% higher revenues.

[Press] W&T Offshore and Baker Hughes, a GE company Announce Strategic Agreement for Joint Exploration & Development Program of 14 Drilling Projects in the Gulf of Mexico

2018-05-02 oilvoice
HOUSTON--(BUSINESS WIRE)--Apr. 30, 2018-- At Offshore Technology Conference (OTC) today, W&T Offshore Inc. (NYSE: WTI) and Baker Hughes, a GE company (NYSE: BHGE) announced a strategic partnership related to W&T's joint exploration and development program, which includes 14 drilling projects, most of which are operated by W&T in the Gulf of Mexico.

Venezuela Stymies Halliburton

2018-04-29 seekingalpha
Halliburton (HAL) reported revenue of $5.74 billion and eps of $0.41. The company missed on revenue by $10 million. The stock has been flat since earnings were released. Below are my takeaways on the quarter:

BHGE / Baker Hughes, a GE company IRANNOTICE

Document 17021 Aldine Westfield Road

3 Energy Stocks to Play a Breakout in Oil

2018-04-27 investorplace
Back in 2014, WTI crude oil prices were north of $100/barrel. This was also a great time for oil stocks.

General Electric's Death Could Be Best For Shareholders

2018-04-25 seekingalpha
Right now, the market is pessimistic regarding General Electric, but the company's true value doesn't appear to be represented by its market price.

Halliburton's (HAL) Earnings Streak Comes to a Halt in Q1

2018-04-23 zacks
Oilfield services behemoth Halliburton Company (HAL - Free Report) reported in-line first quarter profit after robust North American drilling activity on the back of oil pricing strength were offset by problems in Venezuela and frack sand delivery delays.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

12h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

12h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

22h - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 05722G100